Clinical Trials Browser

Phase 2 × Dalteparin × Gastrointestinal × Clear all

Biliary Tract Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

NCT00323011 2014-05-21

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Phase 2 Terminated

5 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00462852 2013-08-12

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

120 enrolled

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Clinical Trials

PRIORITY

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer